| 1 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
QC Testing and STEM-PD primarily use FOXA2 and OTX2 in their experiments. |
The results section shows the methodology and primarily uses FOXA2 and OTX2. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
To obtain more accurate diagnoses and better treatment results. |
AI will help provide precise answers and find ways to create the best possible outcomes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A second medical opinion helps to better inform a doctor's decision-making process. |
AI's ability to provide a second medical opinion helps radiologists make better and more accurate decisions. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
To use AI, one must understand the related knowledge and skills before employing it. |
A thorough understanding of AI is crucial before being able to use it correctly, efficiently, and accurately. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AI machine has no correlation with its influence on adoption. |
Acceptance must come from competence; actions that produce reliable results. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Consensus among healthcare professionals is crucial having a unified opinion leads to greater accuracy in treatment. |
Action-based influence builds trust, fostering confidence in healthcare. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
A potential negative consequence of AI use is a potential reduction in the number of healthcare personnel. |
If healthcare personnel are reduced, it could lead to instability and danger to patients and others if there is no primary decision-making authority. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
To make AI human-centered and maximize its benefits. |
For AI to gain acceptance, it must process the best possible outcomes for humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
System use in the AI adoption factors must include value proposition that provides benefits, and integration into workflows to facilitate and deliver positive results for humans. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ethics and professional values tend to go hand in hand. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
User experience and system integration will help to better understand and improve the application. |
These are crucial methodologies for promoting adoption and maximizing benefits. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
The article clearly states that human embryonic stem cells are used in treatment to replace lost dopamine neurons. |
Human embryonic stem cells can be used to replace dopamine neurons. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
It is clearly stated in the article. |
The article stated that rats were used in the experiments. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
It is stated in highlight. |
The article stated that the entire experiment lasted 9 months. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Phase 1/2a clinical trials are being encouraged. |
The article mentions this in the summary section. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
For safe experimentation, it must be conducted under GMP-compliant conditions.
|
The article states that STEM-PD products must comply with GMP standards. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The absence of any side effects or adverse reactions means the trial is safe. |
The experiment examined and found that the rats were in normal condition with no side effects. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
Experiments have shown that the disorders can be corrected without any side effects. |
The article corrects the deficiencies and has no negative impact. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are irrelevant to the process. |
|
In experimental processes, FGF8b and SHH are not mentioned. |
The article does not relate them to growth factors. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
The muscles of the rats were restored. |
The highlight is the reported improvement in movement impairments in Parkinson's disease rats. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|